BRIEF—Approval for world's first antipsychotic patch

Sumitomo Dainippon Pharma has won approval in Japan for the world’s first transdermal patch formulation of an antipsychotic agent, Lonasen (blonanserin).

The tablet and powder form was launched in Japan for the indication of schizophrenia in April 2008. Since 2010, the firm has worked with Nitto to develop a patch version.

Sumitomo says the new formulation will contribute to the improvement of adherence and treatment of schizophrenia.